Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 454 of the 464 references it cites were found in a registry or an index; 60 of the 171 sources its claims cite were checked for support.

GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review

Open access
De Masi, Roberto, Orlando, Stefania · 2022 · International Journal of Molecular Sciences

Abstract

Glycans are one of the four fundamental macromolecular components of living matter, and they are highly regulated in the cell. Their functions are metabolic, structural and modulatory. In particular, ER resident N-glycans participate with the Glc3Man9GlcNAc2 highly conserved sequence, in protein folding process, where the physiological balance between glycosylation/deglycosylation on the innermost glucose residue takes place, according GANAB/UGGT concentration ratio. However, under abnormal conditions, the cell adapts to the glucose availability by adopting an aerobic or anaerobic regimen of glycolysis, or to external stimuli through internal or external recognition patterns, so it responds to pathogenic noxa with unfolded protein response (UPR). UPR can affect Multiple Sclerosis (MS) and several neurological and metabolic diseases via the BiP stress sensor, resulting in ATF6, PERK and IRE1 activation. Furthermore, the abnormal GANAB expression has been observed in MS, systemic lupus erythematous, male germinal epithelium and predisposed highly replicating cells of the kidney tubules and bile ducts. The latter is the case of Polycystic Liver Disease (PCLD) and Polycystic Kidney Disease (PCKD), where genetically induced GANAB loss affects polycystin-1 (PC1) and polycystin-2 (PC2), resulting in altered protein quality control and cyst formation phenomenon. Our topics resume the role of glycans in cell physiology, highlighting the N-glycans one, as a substrate of GANAB, which is an emerging key molecule in MS and other human pathologies.

Overview

CoChat Summary

TL;DR

This review synthesizes glycobiology and the roles of GANAB/glucosidase II in ER N-glycan processing, unfolded protein response, and human disease. It highlights GANAB dysregulation in multiple sclerosis, polycystic liver/kidney disease, systemic lupus erythematosus, and other conditions, proposing GANAB as a biomarker and therapeutic target.

Key findings

  • GANAB encodes the catalytic α-subunit of glucosidase II (GII), a heterodimer with the β-subunit PRKCSH; the human α-subunit is 944 amino acids with a 912-amino-acid catalytic domain (~103 kDa), and the β-subunit is 528 amino acids (~58 kDa). GII trims glucose residues from the Glc3Man9GlcNAc2 N-glycan in ER glycoprotein quality control.
  • GANAB expression is highest in liver, followed by epididymis ductal cells, with kidney among top expression sites; abnormal GANAB expression is reported in multiple sclerosis (MS), systemic lupus erythematosus, male germinal epithelium, and highly replicating kidney tubule/bile duct cells.
  • In MS, GANAB was upregulated in untreated relapsing-remitting MS patients compared with IFN-treated and other disease-modifying-therapy-treated patients, downregulated in treatment responders versus nonresponders, and higher in healthy controls than untreated RRMS patients; it correlated with lesion load, disease duration, and the Rio score.
  • In autosomal dominant polycystic liver and kidney disease, GANAB mutations cause defective glucose trimming of N-glycan moieties and increased apparent molecular mass of polycystin-1; ADPLD genes explain only 25–30% of the genetic spectrum, and GANAB loss affects polycystin-1/polycystin-2 and cyst formation.

Methods

  • Narrative review of glycobiology, GANAB/glucosidase II structure and function, unfolded protein response, and disease literature; no systematic review protocol or meta-analysis is described.
  • Evidence is drawn from cited experimental, genetic, clinical, and animal studies; no primary data collection or new patient cohort is reported.
  • Main analysis is a qualitative synthesis linking GANAB/N-glycan biology to human physiology and pathologies.

Limitations

  • The authors state that glycomics knowledge is scattered and lacks a holistic/systematic view; for MS, no other published articles on GANAB were available to them; except for MS and polycystic kidney/liver disease, the relation between human pathology and α-glycosidases is only conceivable and not concretely demonstrated; more comprehensive studies are warranted.
  • Evident from the text: as a narrative review, it lacks systematic search/selection criteria and formal quality assessment, so selection bias and reliance on heterogeneous evidence are possible.
  • Evident from the text: conclusions often rest on animal or cell models and correlative human findings, so causality is not established.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms23137373

Cites

454 of 454 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 The ribbon structure of α-Glucosidase II heterodimeric complex. The α-subunit N-terminal trefoil type-P domain is shown in orange, and the N-terminal β-sheet domain is shown in pink. The α-subunit catalytic β8α8 barrel domain is shown in green. The Proximal and Distal α-subunit C-terminal domains are shown in yellow and light brown, respectively. Finally, the β-subunit is shown in blue.
Figure 1 The ribbon structure of α-Glucosidase II heterodimeric complex. The α-subunit N-terminal trefoil type-P domain is shown in orange, and the N-terminal β-sheet domain is shown in pink. The α-subunit catalytic β8α8 barrel domain is shown in green. The Proximal and Distal α-subunit C-terminal domains are shown in yellow and light brown, respectively. Finally, the β-subunit is shown in blue.CC BY · PubMed Central
Figure 2 The human protein atlas of GANAB expression. nTPM normalized expression transcripts per million. (Figure reproduced from https://www.proteinatlas.org/ENSG00000089597-GANAB/tissue, accessed on 5 March 2022).
Figure 2 The human protein atlas of GANAB expression. nTPM normalized expression transcripts per million. (Figure reproduced from https://www.proteinatlas.org/ENSG00000089597-GANAB/tissue, accessed on 5 March 2022).CC BY · PubMed Central
Figure 3 Prognostic relevance of GANAB expression in urothelial cancer (top) and liver cancer (bottom). In both cases, a high expression of this molecule is a marker of an unfavorable clinical outcome. (Figure reproduced from https://www.proteinatlas.org/ENSG00000089597-GANAB/pathology, accessed on 5 March 2022).
Figure 3 Prognostic relevance of GANAB expression in urothelial cancer (top) and liver cancer (bottom). In both cases, a high expression of this molecule is a marker of an unfavorable clinical outcome. (Figure reproduced from https://www.proteinatlas.org/ENSG00000089597-GANAB/pathology, accessed on 5 March 2022).CC BY · PubMed Central

Verification

Claims the paper makes

54 Valid · 22 Not valid · 70 Not checked · 43 Own results and interpretations

85 more claims · 26 with their cited sources checked

Create a free account to see all 189 claims and to verify the 17 references still open.

See all claims — free account
  • It may state two separate claims as one. 56
  • Probably not a substantial claim. 68
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 464 references

Research works printed but not linked: 8

  1. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2022, February 28). Sialic Acids, Essentials of Glycobiology, Available online: https://www.ncbi.nlm.nih.gov/books/NBK1920/.
  2. Taylor, M.E., and Drickamer, K. (2006). Introduction to Glycobiology, Oxford University Press. [2nd ed.].
  3. Varki, A., Cummings, R., Esko, J., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2022, February 28). Essentials of Glycobiology, Available online: https://www.ncbi.nlm.nih.gov/books/NBK20705/.
  4. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2009). N-Glycans. Essentials of Glycobiology, Cold Spring Harbor Laboratory Press.
  5. Voet, D., Voet, J.G., and Pratt, C.W. (1999). Fundamentals of Biochemistry, John Wiley & Sons, Inc.
  6. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2009). O-GalNAc Glycans. Essentials of Glycobiology, Cold Spring Harbor Laboratory Press. [2nd ed.]. Chapter 9.
  7. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2022, February 28). The O-GlcNAc Modification, Essentials of Glycobiology, Available online: https://www.ncbi.nlm.nih.gov/books/NBK453063/.
  8. Janeway, C.A., Travers, P., Walport, M., Walport, M., and Shlomchik, M.J. (2022, February 28). Antigen receptor structure and signaling pathways, Immunobiology: The Immune System in Health and Disease, Available online: https://www.ncbi.nlm.nih.gov/books/NBK27130/.

Cited by

See all 20

Metadata

Authors
De Masi, R., & Orlando, S.
Affiliations
  • Complex Operative Unit of Neurology, “F. Ferrari” Hospital, Casarano, 73042 Lecce, Italy
  • Laboratory of Neuroproteomics, Multiple Sclerosis Centre, “F. Ferrari” Hospital, Casarano, 73042 Lecce, Italy
Corresponding author
Orlando, Stefania
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-07-01
Volume
23
Issue
13
Pages
7373
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4283802200
Cited by
20
References
464
Citations by year
2026: 7 · 2025: 5 · 2024: 3 · 2023: 5
FWCI
0.34
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
Keywords
GANAB, N-glycans, N-acetyl-beta-D-glucosaminidase, polycystic kidney disease, polycystic liver disease, multiple sclerosis, unfolded protein response, polycystin-1, polycystin-2, protein folding, glycosylation, ATF6, PERK, IRE1, BiP, systemic lupus erythematosus, cyst formation
MeSH terms
Glucose, Humans, Male, Multiple Sclerosis, Polysaccharides, TRPP Cation Channels, Unfolded Protein Response

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. https://app.cochat.ai/papers/10.3390/ijms23137373
The paper
De Masi, R., & Orlando, S. (2022). GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23137373

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.